Hyperthermic intraperitoneal chemotherapy combined with systemic chemotherapy for gastric cancer peritoneal carcinomatosis: A protocol for systematic review and meta-analysis of randomized controlled trials

BACKGROUND: The prognosis of gastric cancer peritoneal carcinomatosis (GCPC) remains poor despite recent advances in systemic chemotherapy (SC) with an average survival less than 6 months. Current evidence supporting the utility of hyperthermic intraperitoneal chemotherapy (HIPEC) combined with SC f...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yidan, Jin, Zheng, Zheng, Song, Bai, Yurong, Sun, Yangcheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337564/
https://www.ncbi.nlm.nih.gov/pubmed/32629710
http://dx.doi.org/10.1097/MD.0000000000020973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337564/
https://www.ncbi.nlm.nih.gov/pubmed/32629710
http://dx.doi.org/10.1097/MD.0000000000020973

Ejemplares similares